Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05135845
Title Combination of Capmatinib + Spartalizumab in Advanced Oesogastric Adenocarcinoma (METIMGAST)
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Assistance Publique - Hopitaux de Paris
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Hôpital Jean Minjoz Besançon 25030 France Details
Centre François Leclerc Dijon France Details
Centre Léon Bérard Lyon 69008 France Details
AP-HP Hôpital Saint Louis Paris 75010 France Details
Hôpital Haut Lévêque Pessac 33604 France Details
Institut Universitaire du Cancer Toulouse 31059 France Details
Institut Gustave Roussy Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field